MAAT INDEX

CLAIM #12095 · Bristol-Myers Squibb Company (BMY) · 2024Q4 earnings call · Feb 6, 2025 · due Dec 31, 2030

Specifically, that means increasing the velocity of growth that we have in the last couple of years exiting this decade and into the next.

Chris Boerner · CEO

PENDING
graded after results covering Dec 31, 2030 are reported

How to check this claim

Look at: Company revenue growth rate (year-over-year), as reported

It came true if: Revenue growth rate in years approaching and entering the 2030s exceeds the average annual growth rate of the preceding couple of years (i.e., growth accelerates rather than staying flat or declining)

Where: Company income statement / annual report (10-K) revenue figures

Verify independently

SEC filings for BMY · Claim quote is verbatim from the 2024Q4 earnings call.